484 related articles for article (PubMed ID: 33447084)
1. Identification of Hub Genes as Potential Prognostic Biomarkers in Cervical Cancer Using Comprehensive Bioinformatics Analysis and Validation Studies.
Xue H; Sun Z; Wu W; Du D; Liao S
Cancer Manag Res; 2021; 13():117-131. PubMed ID: 33447084
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
3. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
[TBL] [Abstract][Full Text] [Related]
4. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for Cervical Cancer: A Bioinformatics Analysis.
Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
[TBL] [Abstract][Full Text] [Related]
5. Deciphering cervical cancer-associated biomarkers by integrated multi-omics approach.
Li X; Abdel-Maksoud MA; Iqbal I; Mubarak A; Farrag MA; Haris M; Alghamdi S; Ain QU; Almekhlafi S
Am J Transl Res; 2022; 14(12):8843-8861. PubMed ID: 36628250
[TBL] [Abstract][Full Text] [Related]
6. GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation.
Zhao M; Li X; Chen X
J Bioenerg Biomembr; 2021 Apr; 53(2):177-189. PubMed ID: 33538941
[TBL] [Abstract][Full Text] [Related]
7. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
8. Identification of the Hub Genes Associated with the Prognosis of Ovarian Cancer Patients via Integrated Bioinformatics Analysis and Experimental Validation.
Zhao Y; Pi J; Liu L; Yan W; Ma S; Hong L
Cancer Manag Res; 2021; 13():707-721. PubMed ID: 33542655
[TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential key genes and functional role of CENPF in osteosarcoma using bioinformatics and experimental analysis.
Ma Y; Guo J; Li D; Cai X
Exp Ther Med; 2022 Jan; 23(1):80. PubMed ID: 34934449
[TBL] [Abstract][Full Text] [Related]
11. Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC.
Wu C; Qi X; Qiu Z; Deng G; Zhong L
Aging (Albany NY); 2021 Sep; 13(18):22148-22163. PubMed ID: 34491228
[TBL] [Abstract][Full Text] [Related]
12. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
Front Genet; 2020; 11():530892. PubMed ID: 33061942
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis.
Jin D; Jiao Y; Ji J; Jiang W; Ni W; Wu Y; Ni R; Lu C; Qu L; Ni H; Liu J; Xu W; Xiao M
PeerJ; 2020; 8():e9301. PubMed ID: 32587798
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
[TBL] [Abstract][Full Text] [Related]
15. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
16. Screening and identification of potential biomarkers and therapeutic drugs in melanoma via integrated bioinformatics analysis.
Chen B; Sun D; Qin X; Gao XH
Invest New Drugs; 2021 Aug; 39(4):928-948. PubMed ID: 33501609
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
18. Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis.
Zeng Y; Li N; Chen R; Liu W; Chen T; Zhu J; Zeng M; Cheng J; Huang J
Transl Cancer Res; 2020 Nov; 9(11):7149-7164. PubMed ID: 35117319
[TBL] [Abstract][Full Text] [Related]
19. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
